A new study has found that the level of a person’s immune cells may provide an indication of whether they would benefit from chemotherapy in oropharyngeal cancer.
Some people with head and neck cancer will now have access to the immunotherapy drug pembrolizumab (Keytruda) on the NHS in England.
There’s more to stopping cancer from spreading than simply cutting out chocolate, despite what the headlines say.
Professor Richard Shaw, a mouth cancer specialist who helped create our new Oral Cancer Toolkit, explains why it differs from the NICE referral guidelines
Oral cancer is now the tenth most common cancer in men according to new figures released by Cancer Research UK today.
Emma Shanks shares her story of being diagnosed with oral cancer, not once but four times in succession.